{
  "doc_id": "d8bf90471ff5968cbdaefd032cbea28a776f61b6a6aedcbb879a9a1550ef0eab",
  "chunk_entities": [
    {
      "chunk_id": "ee3db8415a2944c7f8934cce2f5ae17e",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant effects",
          "context": "Antidepressant effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "inhibitors of cAMP phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "phosphodiesterase (PDE4)"
        }
      ]
    },
    {
      "chunk_id": "965d5e31ae90be5dca185dacd7b62c07",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "type 4 phosphodiesterase (PDE4) inhibitors",
          "context": "development of type 4 phosphodiesterase (PDE4) inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "inhibitors as antidepressants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "importance of PDE4 subtypes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "potential of PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "PDE4 has been shown to be involved"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "involved in cAMP signaling pathways"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "affected by antidepressants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "that PDE4D and PDE4B mediate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "PDE4D and PDE4B mediate antidepressant effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "mediate antidepressant effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "conformer of PDE4 is particularly important"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "important for antidepressant efficacy"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "actions of PDE4 inhibitors"
        }
      ]
    },
    {
      "chunk_id": "aa5fb0e435cad9df2e58b5707ff754ae",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "PDE4D has been shown to be regulated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "regulation",
          "context": "of regulation in the brain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "regulated at the expression level",
          "context": "regulated at the expression level in several cell types"
        }
      ]
    },
    {
      "chunk_id": "8a565dbf31f1453b967c49a5c540a569",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant actions",
          "context": "implicated in antidepressant actions"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "involves PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA-receptor",
          "context": "NMDA-receptor-mediated signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA receptors",
          "context": "The role of NMDA receptors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "mediating antidepressant effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA antagonists",
          "context": "NMDA antagonists such as MK801"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MK801",
          "context": "such as MK801 (dizocilpine)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dizocilpine",
          "context": "MK801 (dizocilpine)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant-like effects",
          "context": "produce antidepressant-like effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram has been shown to reverse memory deficits"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reverse memory deficits",
          "context": "reverse memory deficits that result from dizocilpine treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dizocilpine",
          "context": "result from dizocilpine treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "role of PDE4 in NMDA-receptor-mediated signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA-receptor",
          "context": "PDE4 in NMDA-receptor-mediated signaling"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognitive deficits",
          "context": "related more to cognitive deficits"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "that occur in depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "functional role of PDE4 in NMDA receptor-mediated signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA receptor",
          "context": "PDE4 in NMDA receptor-mediated signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA receptors",
          "context": "Stimulation of NMDA receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "concentrations of cAMP and cGMP"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cGMP",
          "context": "cAMP and cGMP"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "the cAMP formed by NMDA-receptor stimulation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA-receptor",
          "context": "cAMP formed by NMDA-receptor stimulation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "hydrolyzed exclusively by PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cGMP",
          "context": "the cGMP that forms is hydrolyzed by PDE2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE2",
          "context": "hydrolyzed by PDE2 only"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 subtypes",
          "context": "which PDE4 subtypes are components"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA-receptor",
          "context": "components of NMDA-receptor-mediated signaling"
        }
      ]
    },
    {
      "chunk_id": "5491df562c325ae25574b24b75a967aa",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant-like profile",
          "context": "exhibit an antidepressant-like profile"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduced immobility",
          "context": "evidenced by reduced immobility"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduced immobility",
          "context": "This reduced immobility is similar"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "putative antidepressant rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduction in immobility",
          "context": "A further reduction in immobility"
        },
        {
          "entity_type": "Compound",
          "entity_name": "desipramine",
          "context": "antidepressants desipramine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "and fluoxetine are administered"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram causes, at best"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduction in the time of immobility",
          "context": "additional reduction in the time of immobility"
        }
      ]
    },
    {
      "chunk_id": "3fcaa03a54b2f6cedb9f791441394f66",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "the ability of rolipram to enhance"
        },
        {
          "entity_type": "Effect",
          "entity_name": "\\beta-adrenoceptor-mediated cAMP formation",
          "context": "enhance \\beta-adrenoceptor-mediated cAMP formation in the cerebral cortex"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "diminished in PDE4D-deficient mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "desipramine",
          "context": "effect of desipramine and fluoxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "effect of desipramine and fluoxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "that PDE4D is not involved"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine-uptake inhibitors",
          "context": "If the monoamine-uptake inhibitors produce their effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "receptor-mediated cAMP formation",
          "context": "by increasing receptor-mediated cAMP formation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 subtype",
          "context": "loss of the PDE4 subtype in the affected pathway"
        },
        {
          "entity_type": "Compound",
          "entity_name": "desipramine",
          "context": "enhance the effects of desipramine and fluoxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "enhance the effects of desipramine and fluoxetine"
        }
      ]
    },
    {
      "chunk_id": "75b2c2fb00b45bdaa16e7d05ef8076c8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "desipramine",
          "context": "treatment with either desipramine or fluoxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "desipramine or fluoxetine, antidepressants"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "antidepressants that exert their antidepressant effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "exert their antidepressant effects primarily"
        },
        {
          "entity_type": "Compound",
          "entity_name": "noradrenaline",
          "context": "via noradrenaline-mediated and 5-HT-mediated actions"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "noradrenaline-mediated and 5-HT-mediated actions"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "increase in PDE4 expression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressants",
          "context": "indicates that the antidepressants alter components"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "these antidepressant effects are secondary"
        }
      ]
    },
    {
      "chunk_id": "b933b9ca948b4f2dc96ff4520056b739",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "desipramine",
          "context": "ability of desipramine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "and fluoxetine to increase"
        },
        {
          "entity_type": "Disease",
          "entity_name": "lesion",
          "context": "lesion of these systems"
        }
      ]
    }
  ],
  "total_entities": 79,
  "extraction_date": "2026-02-01T08:08:53.011518+00:00"
}